Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV (Metastatic) Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00012311
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00063934
What this trial is testing

Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Male Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer+2 more
National Cancer Institute (NCI) 31
Post-approval studies (Phase 4)Study completedNCT01961544
What this trial is testing

Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsBreast Cancer
Eisai Korea Inc. 101
Not applicableLooking for participantsNCT05837767
What this trial is testing

Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more
Memorial Sloan Kettering Cancer Center 26
Not applicableUnknownNCT04628806
What this trial is testing

Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells

Who this might be right for
Melanoma Stage IVSarcomaSquamous Cell Carcinoma+3 more
Charite University, Berlin, Germany 120
Testing effectiveness (Phase 2)Ended earlyNCT00351858
What this trial is testing

Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsBreast Cancer
Neovii Biotech 40
Not applicableWithdrawnNCT01558778
What this trial is testing

Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT00751101
What this trial is testing

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityPalmar-plantar Erythrodysesthesia
University of California, San Francisco 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03202316
What this trial is testing

Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer

Who this might be right for
Recurrent Breast Inflammatory CarcinomaStage IV Breast Inflammatory Carcinoma
M.D. Anderson Cancer Center 37
Early research (Phase 1)UnknownNCT00003412
What this trial is testing

Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation

Who this might be right for
Breast Cancer
Beth Israel Deaconess Medical Center 35
Testing effectiveness (Phase 2)Ended earlyNCT00003432
What this trial is testing

Immunotherapy in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Duke University 4
Testing effectiveness (Phase 2)Study completedNCT02614833
What this trial is testing

IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma

Who this might be right for
Adenocarcinoma Breast Stage IV
Immutep S.A.S. 242
Not applicableLooking for participantsNCT06830382
What this trial is testing

HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC

Who this might be right for
Breast Cancer Stage IVHER2-low Breast CancerMolecular Imaging
Renske Altena 70
Testing effectiveness (Phase 2)Study completedNCT03477396
What this trial is testing

Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor and/or Progesterone Receptor PositiveHER2/Neu NegativeStage IV Breast Cancer AJCC v6 and v7
City of Hope Medical Center 2
Not applicableStudy completedNCT00082654
What this trial is testing

Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00227656
What this trial is testing

Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer

Who this might be right for
Breast CancerMetastatic Cancer
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT02595905
What this trial is testing

Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases

Who this might be right for
Metastatic BRCA Hereditary Breast CarcinomaMetastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+3 more
National Cancer Institute (NCI) 344
Testing effectiveness (Phase 2)Study completedNCT00265733
What this trial is testing

Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 48
Testing effectiveness (Phase 2)Looking for participantsNCT04348747
What this trial is testing

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Triple-Negative Breast Carcinoma+1 more
Roswell Park Cancer Institute 23
Post-approval studies (Phase 4)UnknownNCT05033769
What this trial is testing

Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer

Who this might be right for
Breast Cancer FemaleNeoplasm, BreastBreast Cancer Metastatic
Institut fuer Frauengesundheit 82
Next Page